1. Novartis CEO Narasimhan touts blockbuster pipeline — Eli Lilly’s generic insulin to be half the price of branded counterpart — JNJ’s Invokana closes in on diabetic kidney disease approval -- See more on our front page news

    Got questions about whistleblowing?: Ask a Whistleblower Attorney
    Dismiss Notice
  2. Dealing with a potential legal issue at work?Ask an Employment Attorney -- a chance to discuss employment-related legal issues with a practicing attorney with over 20 years in employment law experience.
    Dismiss Notice

BioDelivery Sciences

Anonymous board for BioDelivery Sciences

Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    41
    Views:
    2,635
  2. anonymous
    Replies:
    27
    Views:
    1,484
  3. anonymous
    Replies:
    8
    Views:
    688
  4. anonymous
    Replies:
    5
    Views:
    377
  5. anonymous
    Replies:
    4
    Views:
    412
  6. anonymous
    Replies:
    23
    Views:
    5,154
  7. anonymous
    Replies:
    42
    Views:
    3,759
  8. anonymous
    Replies:
    19
    Views:
    1,163
  9. anonymous
    Replies:
    113
    Views:
    14,179
  10. anonymous
    Replies:
    9
    Views:
    818
  11. anonymous
    Replies:
    8
    Views:
    1,373
  12. anonymous
    Replies:
    31
    Views:
    4,162
  13. anonymous
    Replies:
    5
    Views:
    1,145
  14. anonymous
    Replies:
    4
    Views:
    2,329
  15. anonymous
    Replies:
    4
    Views:
    1,553
  16. anonymous
    Replies:
    1
    Views:
    1,746
  17. anonymous
    Replies:
    6
    Views:
    3,663

Thread Display Options

Loading...